Probiotics and Their Role in Modulating NF-κB Activity
Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a crucial transcription factor involved in regulating immune responses, inflammation, and cell survival. Chronic activation of NF-κB is associated with various inflammatory diseases, autoimmune disorders, and cancers. Probiotics, which are live microorganisms that confer health benefits to the host, have been shown to modulate NF-κB activity and may serve as a therapeutic strategy for managing conditions associated with chronic inflammation.
Types of Probiotics Beneficial for NF-κB Modulation
Lactobacillus Species
Lactobacillus acidophilus: This strain has demonstrated anti-inflammatory effects by reducing the secretion of pro-inflammatory cytokines and inhibiting NF-κB activation in intestinal epithelial cells (Sun et al., 2020).
Lactobacillus reuteri: Known for its ability to protect against UVB-induced inflammatory responses, L. reuteri has been shown to modulate NF-κB signaling, contributing to its anti-inflammatory properties (Perkins et al., 2019).
Bifidobacterium Species
Bifidobacterium animalis subsp. lactis: This strain, when combined with L. acidophilus, exhibited a stronger anti-inflammatory effect than individual strains, significantly reducing NF-κB activation in response to lipopolysaccharides (LPS) (Sun et al., 2020).
Bifidobacterium bifidum: This strain has been identified as a promising candidate for probiotic intervention in inflammatory diseases of the gastrointestinal tract, showing potential in modulating NF-κB activity (Sun et al., 2020).
Saccharomyces Species
Saccharomyces boulardii: This probiotic yeast is effective in treating gastrointestinal disorders and has been shown to inhibit NF-κB activation, thereby reducing inflammation (Beamer et al., 2012).
Other Probiotic Strains
Bacillus cereus: Certain strains of Bacillus have been found to enhance immune responses and modulate NF-κB signaling pathways, contributing to improved gut health (Beamer et al., 2012).
Paracoccus marcusii: This strain has been studied for its effects on immune-related gene expression and its potential to influence NF-κB signaling in marine organisms (Beamer et al., 2012).
Mechanisms of Action
Probiotics exert their anti-inflammatory effects through various mechanisms, including:
Modulation of Cytokine Production: Probiotics can decrease the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-8 while increasing anti-inflammatory cytokines like IL-10 (Sadik & Luster, 2011).
Inhibition of NF-κB Activation: Probiotics can inhibit the phosphorylation and degradation of IκB proteins, preventing the translocation of NF-κB to the nucleus and subsequent gene expression of inflammatory mediators (Serhan & Levy, 2018; Muralidharan & Mandrekar, 2013).
Regulation of Gut Barrier Function: Probiotics enhance the integrity of the intestinal barrier, reducing the translocation of pathogens and inflammatory stimuli that can activate NF-κB (Cara et al., 2019).
Clinical Implications
The modulation of NF-κB by probiotics presents a promising therapeutic avenue for various diseases associated with chronic inflammation, including:
Inflammatory Bowel Disease (IBD): Probiotics have been shown to improve symptoms and reduce inflammation in conditions like Crohn’s disease and ulcerative colitis by modulating NF-κB signaling (Serhan & Levy, 2018; Cara et al., 2019).
Irritable Bowel Syndrome (IBS): Probiotic supplementation may alleviate symptoms of IBS by reducing gut inflammation and restoring microbial balance (Dong, 2020).
Metabolic Disorders: Probiotics can improve insulin sensitivity and reduce inflammation in obesity and type 2 diabetes by modulating NF-κB activity (Dong, 2020).
Respiratory Diseases: Probiotics may help manage chronic respiratory conditions by modulating immune responses and reducing inflammation (Machairiotis et al., 2021).
Conclusion
Probiotics, particularly strains such as Lactobacillus, Bifidobacterium, and Saccharomyces, have shown promise in modulating NF-κB activity and reducing inflammation. Their ability to influence immune responses makes them valuable in managing chronic inflammatory diseases. Further research is needed to fully elucidate the mechanisms by which probiotics exert their effects and to optimize their use in clinical practice.
References
1. Li et al. “Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells” *Nutrients* (2019) doi:10.3390/nu11050969.
2. Patra et al. “Effects of Probiotics at the Interface of Metabolism and Immunity to Prevent Colorectal Cancer-Associated Gut Inflammation: A Systematic Network and Meta-Analysis With Molecular Docking Studies” *Frontiers in Microbiology* (2022) doi:10.3389/fmicb.2022.878297.
3. Golfetto et al. “LOWER BIFIDOBACTERIA COUNTS IN ADULT PATIENTS WITH CELIAC DISEASE ON A GLUTEN-FREE DIET” *Arquivos de Gastroenterologia* (2014) doi:10.1590/s0004-28032014000200013.
4. Yang et al. “Effects of dietary Bacillus cereus G19, B. cereus BC-01, and Paracoccus marcusii DB11 supplementation on the growth, immune response, and expression of immune-related genes in coelomocytes and intestine of the sea cucumber (Apostichopus japonicus Selenka)” *Fish & Shellfish Immunology* (2015) doi:10.1016/j.fsi.2015.05.032.
5. Khmaladze et al. “Lactobacillus reuteri DSM 17938—A comparative study on the effect of probiotics and lysates on human skin” *Experimental Dermatology* (2019) doi:10.1111/exd.13950.
6. Askandar and Ebrahimi “The Impact of Probiotics in Respiratory Diseases” *Polytechnic Journal* (2020) doi:10.25156/ptj.v10n1y2020.pp148-156.
7. Patra et al. “Effects of Probiotics at the Interface of Metabolism and Immunity to Prevent Colorectal Cancer-Associated Gut Inflammation: A Systematic Network and Meta-Analysis With Molecular Docking Studies” *Frontiers in Microbiology* (2022) doi:10.3389/fmicb.2022.878297.
8. Nelwan “Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis” *BMC Infectious Diseases* (2024) doi:10.1186/s12879-024-09259-3.
9. Corridoni et al. “Probiotic Bacteria Regulate Intestinal Epithelial Permeability in Experimental Ileitis by a TNF-Dependent Mechanism” *PLOS ONE* (2012) doi:10.1371/journal.pone.0042067.
10. Gomes et al. “Gut microbiota, probiotics and diabetes” *Nutrition Journal* (2014) doi:10.1186/1475-2891-13-60.
11. Mortaz et al. “Probiotics in the Management of Lung Diseases” *Mediators of Inflammation* (2013) doi:10.1155/2013/751068.
More Articles You May Like
Medical Disclaimer
The information provided in this document is intended for educational and informational purposes only and should not be construed as medical advice, diagnosis, or treatment. It is essential to consult a qualified healthcare professional for any medical concerns or conditions. The content herein does not substitute for professional medical advice, and individuals should not disregard or delay seeking medical advice based on the information provided.
The authors and publishers of this document do not assume any responsibility for any adverse effects or consequences resulting from the use or application of the information contained herein. The reader is encouraged to conduct their own research and consult with healthcare providers to make informed decisions regarding their health and treatment options. Furthermore, the information presented may not reflect the most current research or medical guidelines, as medical knowledge is continually evolving. Therefore, it is imperative to verify the information with up-to-date, peer-reviewed sources and consult with medical professionals for personalized advice.











